ICF International, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ICF International, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $321.17M | Feb 28, 2018 |
| FY2017 | Sep 30, 2017 | $305.30M | Feb 28, 2018 |
| FY2017 | Jun 30, 2017 | $306.39M | Feb 28, 2018 |
| FY2017 | Mar 31, 2017 | $296.30M | Feb 28, 2018 |
| FY2017 | Dec 31, 2016 | $289.56M | Feb 28, 2018 |
| FY2017 | Sep 30, 2016 | $306.52M | Feb 28, 2018 |
| FY2017 | Jun 30, 2016 | $305.42M | Feb 28, 2018 |
| FY2017 | Mar 31, 2016 | $283.60M | Feb 28, 2018 |
| FY2016 | Dec 31, 2015 | $280.81M | Feb 28, 2017 |
| FY2016 | Sep 30, 2015 | $288.95M | Feb 28, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.87B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.02B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.96B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.78B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $1.55B | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | $434.34M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $360.32M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $353.99M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $358.24M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $396.64M | Feb 26, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $91.59M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $110.17M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $82.61M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $64.24M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $71.13M | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | $12.82M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $17.87M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $13.66M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $10.61M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $19.38M | Feb 26, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $145.47M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $165.84M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $132.32M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $108.76M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $110.94M | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | $21.76M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $28.25M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $22.78M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $16.32M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $28.30M | Feb 26, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $492.40M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $518.45M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $505.16M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $486.86M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $430.57M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $411.61M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $395.76M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $360.99M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $346.44M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $328.05M | Feb 27, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $141.87M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $171.54M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $152.38M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $162.21M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $110.21M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $173.15M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $91.44M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $74.67M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $117.19M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $80.06M | Feb 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.05B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.07B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.01B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.09B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.85B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $1.67B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.40B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.21B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $1.11B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $1.09B | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.02B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.08B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.09B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.24B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.05B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $920.33M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $681.48M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $553.45M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $494.23M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $519.57M | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.03B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $982.46M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $917.59M | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $853.21M | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | $803.47M | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | $746.96M | Feb 28, 2024 |
| FY2022 | Dec 31, 2019 | $714.55M | Mar 1, 2023 |
| FY2021 | Dec 31, 2018 | $660.42M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $616.03M | Feb 26, 2021 |
| FY2019 | Dec 31, 2016 | $566.00M | Feb 28, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.25B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.25B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.22B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.21B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $1.05B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $909.91M | Mar 1, 2023 |
| FY2022 | Dec 31, 2019 | $1.05B | Mar 1, 2023 |
| FY2020 | Dec 31, 2018 | $715.64M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $686.11M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $683.68M | Feb 27, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $956.08M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $874.77M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $775.10M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $703.03M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $649.30M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $588.73M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $544.84M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $486.44M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $434.77M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $371.89M | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.30M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $4.96M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $6.36M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $11.26M | Feb 28, 2025 |
| FY2024 | Dec 31, 2021 | $8.25M | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | $13.84M | Feb 28, 2024 |
| FY2022 | Dec 31, 2019 | $6.48M | Mar 1, 2023 |
| FY2021 | Dec 31, 2018 | $11.69M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $11.81M | Feb 26, 2021 |
| FY2019 | Dec 31, 2016 | $6.04M | Feb 28, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $401.36M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $411.74M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $430.41M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $556.33M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $421.61M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $313.21M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $164.26M | Feb 26, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 26, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 26, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18.25M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 18.67M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 18.85M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | 18.88M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 18.88M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | 18.91M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 18.87M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 18.82M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | 18.66M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | 19.02M | Feb 28, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.36M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $10.51M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $10.54M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $10.55M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $10.57M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $10.55M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $10.54M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $7.92M | Feb 26, 2021 |